Literature DB >> 27513271

Molecular prevalence and antibiotics resistance pattern of class A bla CTX-M-1 and bla TEM-1 beta lactamases in uropathogenic Escherichia coli isolates from Pakistan.

Hazır Rahman1, Madiha Naeem1, Il Khan1, Jafar Khan1, Mohammad Haroon2, Fazli Bari3, Rahim Ullah1, Muhammad Qasim1.   

Abstract

BACKGROUND/AIM: Extended spectrum beta lactamase (ESBL) production among E. coli is one of the principal mechanisms that augment resistance to antibiotics. In the current study the molecular detection of class A beta lactamases among uropathogenic Escherichia coli was evaluated.
MATERIALS AND METHODS: A total of 355 urine samples were collected from a tertiary care hospital in Peshawar. The ESBL production among E. coli isolates was detected by using the disc synergy diffusion method. Moreover, the molecular detection of bla TEM-1 and bla CTX-M-1 ESBLs, the antibiotic resistance pattern, and the minimum inhibitory concentrations (MICs) were also documented.
RESULTS: Among the 355 urine samples, 157 isolates were E. coli, and 23.56% of the isolates were ESBL E. coli. Among phenotypic ESBL producers, bla CTX-M-1 and bla TEM-1 were found in 59.45% and 40.54% of the isolates, respectively. A high resistance rate was observed against aztreonam (97.29%), while the lowest resistance was observed against imipenem (2.7%). The MICs of ESBLs E. coli for ceftriaxone, ciprofloxacin, and gentamicin was >512 µg/mL, 4 µg/mL to 128 µg/mL, and 1 µg/mL to 14 µg/mL respectively.
CONCLUSION: The present study showed that bla CTX-M-1 ESBL production is more prevalent in our clinical E. coli isolates. More often the ESBLs were resistant to commonly used antibiotics.

Entities:  

Keywords:  E. coli; ESBLS; Urinary tract infection; antibiotics profile; bla CTX-M-1; bla TEM-1

Mesh:

Substances:

Year:  2016        PMID: 27513271     DOI: 10.3906/sag-1502-14

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  2 in total

1.  Molecular Epidemiology of mcr-1, bla KPC-2, and bla NDM-1 Harboring Clinically Isolated Escherichia coli from Pakistan.

Authors:  Hazrat Bilal; Tayyab Ur Rehman; Muhammad Asif Khan; Fareeha Hameed; Zhang Gao Jian; Jianxiong Han; Xingyuan Yang
Journal:  Infect Drug Resist       Date:  2021-04-16       Impact factor: 4.003

2.  Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.

Authors:  Samyyia Abrar; Shahida Hussain; Rehan Ahmad Khan; Noor Ul Ain; Hayat Haider; Saba Riaz
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-20       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.